Accutane Ruling Raises Bar For Garden State Labeling Claims

By Emily Field (October 5, 2018, 5:54 PM EDT) -- The New Jersey Supreme Court has raised the bar for proving false labeling claims against drug and device companies in the Garden State with a ruling that ended more than 500 cases alleging F. Hoffmann-LaRoche Inc. didn't adequately warn of possible gastrointestinal side effects from its acne drug Accutane....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!